BSE Live
Feb 25, 16:01Prev. Close
1544.70
Open Price
1560.90
Bid Price (Qty.)
1525.20 (1)
Offer Price (Qty.)
1569.00 (1)
NSE Live
Feb 25, 15:42Prev. Close
1548.10
Open Price
1555.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Hester Biosciences (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 41.23 | 59.75 | 43.71 | 33.09 | 24.85 | |
| Net CashFlow From Operating Activities | 25.82 | 36.19 | 32.28 | 27.55 | 18.81 | |
| Net Cash Used In Investing Activities | -21.33 | -24.70 | -26.32 | -15.49 | -5.85 | |
| Net Cash Used From Financing Activities | -1.39 | -20.29 | -6.24 | -5.60 | -11.92 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 3.10 | -8.80 | -0.28 | 6.46 | 1.04 | |
| Cash And Cash Equivalents Begin of Year | 2.09 | 10.89 | 11.17 | 4.71 | 3.92 | |
| Cash And Cash Equivalents End Of Year | 5.19 | 2.09 | 10.89 | 11.17 | 4.96 |
03.02.2026
Hester Bio Consolidated December 2025 Net Sales at Rs 77.42 crore, up 22.46% Y-o-Y
03.02.2026
Hester Bio Standalone December 2025 Net Sales at Rs 70.35 crore, up 11.98% Y-o-Y
19.11.2025
Hester Bio Consolidated September 2025 Net Sales at Rs 70.97 crore, down 15.2% Y-o-Y
18.11.2025
Hester Bio Standalone September 2025 Net Sales at Rs 64.58 crore, down 12.14% Y-o-Y
03.02.2026
Hester Bio Consolidated December 2025 Net Sales at Rs 77.42 crore, up 22.46% Y-o-Y
03.02.2026
Hester Bio Standalone December 2025 Net Sales at Rs 70.35 crore, up 11.98% Y-o-Y
19.11.2025
Hester Bio Consolidated September 2025 Net Sales at Rs 70.97 crore, down 15.2% Y-o-Y
18.11.2025
Hester Bio Standalone September 2025 Net Sales at Rs 64.58 crore, down 12.14% Y-o-Y